Targeted agent shows promise in biliary cancer study

An experimental agent has shown promising results in people with advanced biliary cancer, according to a multi-institutional clinical trial led by cancer researchers at the Ohio State University.

If you want to include this story in your blog, copy and paste this formatted text: